Document is current
Any future updates will be listed below
-
Authors
Biose, Ifechukwude Joachim
Rutkai, Ibolya
Clossen, Bryan
Gage, Gary
Schechtman, Kenneth
Adkisson, H. Davis IV https://orcid.org/0000-0001-6507-0016
Bix, Gregory J. https://orcid.org/0000-0002-8969-9553
- License Information
-
More Information
Article History
Received: 13 June 2022
Revised: 1 September 2022
Accepted: 20 September 2022
First Online: 12 December 2022
Declarations
:
: All animal procedures were approved by the STILLMEADOW, Inc. or Tulane University Institutional Animal Care and Use Committees. Planning, experimental procedures, group treatments, data analysis, documentation, and reporting were conducted in accordance with ARRIVE guidelines 2.0 ().
: All authors give their consent and approval for publication of this manuscript.
: BC, GG and HDA are employees of Stream Biomedical Inc. which is actively exploring the therapeutic benefits of rhPDV and rhPDV<sub>LG3</sub>
: BC, GG, and HDA are employees of Stream Biomedical Inc. which is actively exploring the therapeutic benefits of rhPDV and rhPDV<sub>LG3</sub>. All other authors declare no competing interests.
